Samalin Investment Counsel, LLC Amarin Corp Plcuk Transaction History

Samalin Investment Counsel, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.13 - $3.69 $683 - $2,232	-605 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$3.94 - $5.84 $748 - $1,109	-190 Reduced 23.9%	605 $3.09 Million
Q2 2021 Aug 12, 2021	BUY	$4.26 - $6.5 $3,386 - $5,167	795 New	795 $3,000
Q1 2021 May 11, 2021	SELL	$5.03 - $8.8 $3,998 - $6,996	-795 Closed	0 $0
Q3 2020 Nov 10, 2020	BUY	$3.64 - $7.76 $2,893 - $6,169	795 New	795 $3,000
Q1 2020 May 04, 2020	SELL	$4.0 - $21.53 $2,420 - $13,025	-605 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$13.94 - $24.12 $8,433 - $14,592	605 New	605 $12,000

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $190M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Samalin Investment Counsel, LLC, based on Form 13F filings with the SEC.

Stay updated on Samalin Investment Counsel, LLC with notifications on news.